Literature DB >> 27462117

Incidence and Predictors of Early Recanalization After Intravenous Thrombolysis: A Systematic Review and Meta-Analysis.

Pierre Seners1, Guillaume Turc2, Benjamin Maïer1, Jean-Louis Mas1, Catherine Oppenheim1, Jean-Claude Baron1.   

Abstract

BACKGROUND AND
PURPOSE: After the demonstration of efficacy of bridging therapy, reliably predicting early recanalization (ER; ≤3 hours after start of intravenous thrombolysis) would be essential to limit futile, resource-consuming, interhospital transfers. We present the first systematic review on the incidence and predictors of ER after intravenous thrombolysis alone.
METHODS: We systematically searched for studies including patients solely treated by intravenous thrombolysis that reported incidence of ER and its association with baseline variables. Using meta-analyses, we estimated pooled incidence of ER, including according to occlusion site, and summarized the available evidence regarding predictors of no-ER.
RESULTS: We identified 26 studies that together included 2063 patients. The overall incidence of partial or complete ER was 33% (95% confidence interval, 27-40). It varied according to occlusion site: 52% (39-64) for distal middle cerebral artery, 35% (28-42) for proximal middle cerebral artery, 13% (6-22) for intracranial carotid artery, and 13% (0-35) for basilar occlusion. Corresponding rates for complete ER were 38% (22-54), 21% (15-29), 4% (1-8), and 4% (0-22), respectively. Proximal occlusion and higher National Institute of Health Stroke Scale were the most consistent no-ER predictors. Other factors, such as long or totally occlusive thrombus and poor collateral circulation, emerged as potential predictors but will need confirmation.
CONCLUSION: The overall incidence of ER after intravenous thrombolysis is substantial, highlighting the importance of reliably predicting ER to limit futile, interhospital transfers. Incidence of no-ER is particularly high for proximal occlusion and severe strokes. Given the scarcity of published data, further studies are needed to improve no-ER prediction accuracy.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  endovascular procedures; fibrinolysis; incidence; meta-analysis; stroke; thrombectomy

Mesh:

Substances:

Year:  2016        PMID: 27462117     DOI: 10.1161/STROKEAHA.116.014181

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  46 in total

1.  The Efficacy of IV Tissue Plasminogen Activator for Restoring Cerebral Blood Flow in the Hours Immediately after Administration in Patients with Acute Stroke.

Authors:  Shahram Majidi; Alexis N Simpkins; Richard Leigh
Journal:  J Neuroimaging       Date:  2018-12-03       Impact factor: 2.486

Review 2.  A new era for stroke therapy: Integrating neurovascular protection with optimal reperfusion.

Authors:  Ligen Shi; Marcelo Rocha; Rehana K Leak; Jingyan Zhao; Tarun N Bhatia; Hongfeng Mu; Zhishuo Wei; Fang Yu; Susan L Weiner; Feifei Ma; Tudor G Jovin; Jun Chen
Journal:  J Cereb Blood Flow Metab       Date:  2018-09-07       Impact factor: 6.200

3.  Two Paradigms for Endovascular Thrombectomy After Intravenous Thrombolysis for Acute Ischemic Stroke.

Authors:  Gaspard Gerschenfeld; Ioan-Paul Muresan; Raphael Blanc; Michael Obadia; Marie Abrivard; Michel Piotin; Sonia Alamowitch
Journal:  JAMA Neurol       Date:  2017-05-01       Impact factor: 18.302

4.  Relationships between brain perfusion and early recanalization after intravenous thrombolysis for acute stroke with large vessel occlusion.

Authors:  Pierre Seners; Guillaume Turc; Stéphanie Lion; Jean-Philippe Cottier; Tae-Hee Cho; Caroline Arquizan; Serge Bracard; Canan Ozsancak; Laurence Legrand; Olivier Naggara; Séverine Debiais; Yves Berthezene; Vincent Costalat; Sébastien Richard; Christophe Magni; Norbert Nighoghossian; Ana-Paula Narata; Cyril Dargazanli; Benjamin Gory; Jean-Louis Mas; Catherine Oppenheim; Jean-Claude Baron
Journal:  J Cereb Blood Flow Metab       Date:  2019-03-19       Impact factor: 6.200

5.  Recanalization of Emergent Large Intracranial Vessel Occlusion through Intravenous Thrombolysis: Frequency, Clinical Outcome, and Reperfusion Pattern.

Authors:  Carmen Serna Candel; Marta Aguilar Pérez; Victoria Hellstern; Muhammad AlMatter; Hansjörg Bäzner; Hans Henkes
Journal:  Cerebrovasc Dis       Date:  2019-11-20       Impact factor: 2.762

6.  Basilar artery occlusion and unwarranted clinical trials.

Authors:  Magnus Kaijser; Staffan Holmin
Journal:  Interv Neuroradiol       Date:  2019-09-05       Impact factor: 1.610

7.  [Collateral circulation and Toll-like receptor 4 levels in patients with acute cerebral infarction after intravenous thrombolysis].

Authors:  Zhengxiang Ji; Qi Fang; Liqiang Yu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-05-30

Review 8.  Nucleic Acid Therapies for Ischemic Stroke.

Authors:  Nils Henninger; Yunis Mayasi
Journal:  Neurotherapeutics       Date:  2019-04       Impact factor: 7.620

Review 9.  Successful Reperfusion With Intravenous Thrombolysis Preceding Mechanical Thrombectomy in Large-Vessel Occlusions.

Authors:  Georgios Tsivgoulis; Aristeidis H Katsanos; Peter D Schellinger; Martin Köhrmann; Panayiotis Varelas; Georgios Magoufis; Maurizio Paciaroni; Valeria Caso; Anne W Alexandrov; Edip Gurol; Andrei V Alexandrov
Journal:  Stroke       Date:  2017-12-06       Impact factor: 7.914

10.  Acute ischemic stroke thrombi have an outer shell that impairs fibrinolysis.

Authors:  Lucas Di Meglio; Jean-Philippe Desilles; Véronique Ollivier; Mialitiana Solo Nomenjanahary; Sara Di Meglio; Catherine Deschildre; Stéphane Loyau; Jean-Marc Olivot; Raphaël Blanc; Michel Piotin; Marie-Christine Bouton; Jean-Baptiste Michel; Martine Jandrot-Perrus; Benoît Ho-Tin-Noé; Mikael Mazighi
Journal:  Neurology       Date:  2019-09-20       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.